官方服务：
资源简介：
MOLM-14 cell resistance to Tuspetinib.
应用场景：
创建时间：
2024-12-04
相关数据集
Gilteritinib Resistant MOLM-14 and MV4;11 Whole Exome Sequencing
In this study, we utilized a two-step approach to reveal temporal evolution of gilteritinib resistance. We cultured AML cells with exogenous protective factors that are normally secreted by marrow str
NIAID Data Ecosystem40
Upregulated cholesterol biosynthesis facilitates the survival of methylation-retaining AML cells following decitabine treatment [single_colony_TEM-Seq]
DNA hypomethylating agents (HMAs) are used to treat acute myeloid leukaemia (AML) and myelodysplasia patients who are unsuitable for intensive chemotherapy, but low response rates and therapy-resistan
NIAID Data Ecosystem20
Gene Expression Analysis of Ara-C Resistance in AML
Using two independently derived murine BXH2 cell lines, Ara-C resistant derivatives were developed by exposure to increasing concentrations of Ara-C. Microarray analysis comparing the Ara-C resistant
NIAID Data Ecosystem20
Table S7 from Single-Cell Lineage Tracing Uncovers Resistance Signatures and Sensitizing Strategies to FLT3 Inhibitors in Acute Myeloid Leukemia
Table S7 shows genes significantly and specifically up-regulated in midostaurin pre-resistant cells.
NIAID Data Ecosystem20
Targeted nanopore sequencing for the identification of ABCB1 promoter translocations in relapsed acute myeloid leukemia [4C-seq]. Targeted nanopore sequencing for the identification of ABCB1 promoter translocations in relapsed acute myeloid leukemia [4C-seq]
Resistance to chemotherapy is the most common cause of treatment failure in acute myeloid leukemia and the drug efflux pump ABCB1 is a critical mediator. Here we demonstrate that in vitro daunorubicin
NIAID Data Ecosystem20
